Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06898034 · ClinicalTrials.gov registry record
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
A clinical trial of Pregnancy Related and Postpartum Hemorrhage, sponsored by Endeavor Health.
- Recruiting
- Registry status
- 1,725
- Enrollment target
- 1
- Study location
NCT06898034: Recruiting study of Pregnancy Related and Postpartum Hemorrhage, sponsored by Endeavor Health.
NCT06898034 is a study of Pregnancy Related and Postpartum Hemorrhage that is actively recruiting participants, run by Endeavor Health. The registered enrollment target is 1,725 participants, below the 1,946-participant average among 99 other Pregnancy Related trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06898034, a study of Pregnancy Related and Postpartum Hemorrhage, is actively recruiting participants, sponsored by Endeavor Health.
- RECRUITING
- Registry status
- 1,725 participants
- Enrollment target
- 1
- Study location
Study Summary
Up to 5% of patients in the United States have a postpartum hemorrhage. "Postpartum hemorrhage" means excessive bleeding after delivery. The majority of these bleeds occur immediately with delivery. The current study focuses on hemorrhages that occur in the "medium-term" (1.5-24 hours after delivery). Investigators are examining whether ultrasound exams performed at the beginning of this period 1.5 to 2 hours after birth can identify markers that predict a medium-term bleed. Data collected for this study will include medical and obstetrical history, details about the course and outcomes of patients' labor and delivery, and particulars about postpartum bleeding. This information will be collected through the end of the patients' delivery admission and will allow correlation with the results of the ultrasound exam. If patients are re-admitted to the hospital after the delivery discharge, investigators may also collect relevant information about those admissions up to 6 weeks postpartum. All patients after term delivery (≥ 37 weeks' gestation) will be eligible to participate. Patients will be approached to provide consent for participation as early as feasible during a prenatal visit (≥ 36 weeks' gestation) or during the delivery admission. No subjects will be consented while in significant pain, \>6cm dilated without an epidural, or \>8cm dilatated with an epidural.
Primary Outcome
* Uterine length (cm) * Uterine width (cm) * Uterine height (cm) These will be correlated with subsequent clinical outcomes, including bleeding events.
Conditions Studied
Interventions
- OTHER Ultrasound
Study Locations (1)
Illinois
- Endeavor Health - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,725 participants |
| Start Date | 2025-03-10 |
| Est. Completion | 2027-03 |
What NCT06898034 shows while recruiting
NCT06898034 is an observational study that tracks outcomes without assigning an intervention. Its 1,725 participants enrollment target places it among the larger protocols in the corpus, below the 1,946-participant average among 99 other Pregnancy Related trials with a reported enrollment target (11% lower).
The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.
NCT06898034 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06898034 about?
NCT06898034 is a clinical study titled "Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage". Up to 5% of patients in the United States have a postpartum hemorrhage. "Postpartum hemorrhage" means excessive bleeding after delivery. The majority of these bleeds occur immediately with delivery. The current study focuses on hemorrhages that occur in the "medium-term" (1.5-24 hours after deliver...
What is the current status of trial NCT06898034?
This trial is currently recruiting. The enrollment target is 1,725 participants. The study started on 2025-03-10. Estimated completion is 2027-03.
What conditions does trial NCT06898034 study?
This clinical trial studies the following conditions: Pregnancy Related, Postpartum Hemorrhage.
What interventions are being tested in trial NCT06898034?
The interventions under investigation include: Ultrasound (OTHER).
Who is sponsoring clinical trial NCT06898034?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06898034 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06898034's enrollment target sits among peer trials
1,725 11th of 99 higher than 89 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06413420 · 1,731 participants
SUNOSI® (Solriamfetol) Pregnancy Registry
- NCT04291612 · 1,715 participants
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- NCT04712656 · 1,739 participants
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
- NCT05303636 · 1,710 participants · Phase 4
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI